Additionally, tazemetostat has been found to enhance 5‐FU‐induced apoptosis by upregulating PUMA (p53 upregulated modulator of apoptosis) and activating the mitochondrial apoptosis pathway in colorectal cancer [49]. This evidence concerns the gene TP53 and colorectal cancer.